ACTRN12619001017112已完成1 期
A single dose, blinded, balanced, randomised, three-treatment, three period, six sequence, three-way crossover bioequivalence study comparing an immediate release tablet containing 500 mg paracetamol / 200 mg ibuprofen / 5.1 mg doxylamine with Dolased® immediate release tablets containing 500 mg paracetamol / 10 mg codeine phosphate hemihydrate / 5.1 mg doxylamine succinate and Nuromol® immediate release tablets containing 500 mg paracetamol / 200 mg ibuprofen in healthy male and female subjects under fasting conditions.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •Healthy males and females
- •Aged between 18 and 55
- •Non-smoker
- •BMI between 18.5 and 32 inclusive
- •Normal, healthy individuals as determined by medical history, physical examination, ECG, blood pressure and laboratory tests
- •Able to provide written informed consent
排除标准
- •Any history of recent recurrent attacks of bronchitis, asthma, migraine headaches
- •Concomitant drug therapy of any kind
- •Sensitivity to any of the medicines or ingredients
- •History of any conditions that might interfere with the absorption, distribution, metabolism or excretion of the drug
- •Smoker (anyone who has smoked in the last 6 months)
- •History of alcohol or drug abuse or dependency
- •Participation in a drug study within 60 days of the start of the study or donated blood in the 30 days preceding the study.
- •Volunteers for whom the Clinical Investigator believes, for any reason, that participation would not be an acceptable risk
研究者
相似试验
撤回
1 期
Comparative assessment of the absorption of a generic formulation of 4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol hydrogen tartrate oral liquid against the innovator 4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol hydrogen tartrate oral liquid conducted under fasting conditions in healthy male and female volunteers.4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol hydrogen tartrate oral liquid is used to provide temporary relief for persistent unproductive and dry coughsAnaesthesiology - Pain managementInflammatory and Immune System - Other inflammatory or immune system disordersRespiratory - Other respiratory disorders / diseasesACTRN12621001252808Zenith Technology Corporation Limited30
已完成
1 期
Comparative assessment of the absorption of a generic formulation of (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid tablets against the innovator (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid tablets conducted under fasting conditions in healthy male and female volunteers(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid is used for the treatment of management of demonstrated thyroid hormone deficiency.Metabolic and Endocrine - Thyroid diseaseACTRN12620000191998Zenith Technology Corporation Limited25
已完成
1 期
Comparative assessment of the absorption of a generic formulation of 5 mg oxycodone tablet against the innovator 5 mg oxycodone tablet conducted under fasting conditions in healthy male and female volunteers.ACTRN12613001286730Zenith Technology Corporation Limited24
已完成
1 期
Comparative assessment of the absorption of two generic formulations of doxycycline delayed release capsule against the innovator doxycycline delayed release tablet conducted under fasting conditions in healthy male and female volunteersPilot bioequivalence study conducted in healthy volunteers comparing three formulations of doxycycline with no health condition or problem studied. Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, doxycycline belongs to a class of medicines called a tetracyclines that are used to treat a wide range of organisms and work by killing or stopping the growth of bacteria, which cause infections or make acne worse.Pilot bioequivalence study conducted in healthy volunteers comparing three formulations of doxycycline with no health condition or problem studied.Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, doxycycline belongs to a class of medicines called a tetracyclines that are used to treat a wide range of organisms and work by killing or stopping the growth of bacteria, which cause infections or make acne worse.Other - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12614000267651Zenith Technology Corp Ltd12
进行中（未招募）
不适用
A single dose, randomised, double blind, double dummy, placebo-controlled, three-period crossover clinical study, comparing the efficacy, safety and tolerability of Formoterol-HFA pMDI 12 microgram per actuation administered by means of a spacer device (AeroChamber Plus) with that of Formoterol-HFA pMDI 12 microgram per actuation in 5- to 12-year-old children with persistent moderate to severe asthmaPersistent moderate to severe childhood asthma (5 to 12 years of age, inclusive)MedDRA version: 8.1Level: PTClassification code 10049585EUCTR2006-000907-41-HUChiesi Farmaceutici S.p.A.42